<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Introduction • SimTOST</title>
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js" integrity="sha512-v2CJ7UaYy4JwqLDIrZUI/4hqeoQieOmAZNXBeQyjo21dadnwR+8ZaIJVT8EE2iyI61OV8e6M8PP2/4hpQINQ/g==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="Introduction">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body data-spy="scroll" data-target="#toc">


    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">SimTOST</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.3.0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles

    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/intopkg.html">Introduction</a>
    </li>
    <li>
      <a href="../articles/sampleSize_crossover.html">Bioequivalence Tests for 2x2 Cross-Over Trial Designs with Log-Normal Data</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_2A3E.html">Bioequivalence Tests for Parallel Trial Designs: 2 Arms, 3 Endpoints</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel_3A1E.html">Bioequivalence Tests for Parallel Trial Designs: 3 Arms, 1 Endpoint</a>
    </li>
    <li>
      <a href="../articles/sampleSize_parallel.html">Bioequivalence Tests for Parallel Trial Designs with Log-Normal Data</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/smartdata-analysis-and-statistics/SimTOST/" class="external-link">
    <span class="fab fa-github fa-lg"></span>

  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1 data-toc-skip>Introduction</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/smartdata-analysis-and-statistics/SimTOST/blob/main/vignettes/intopkg.Rmd" class="external-link"><code>vignettes/intopkg.Rmd</code></a></small>
      <div class="hidden name"><code>intopkg.Rmd</code></div>

    </div>

    
    
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://github.com/smartdata-analysis-and-statistics/SimTOST" class="external-link">SimTOST</a></span><span class="op">)</span></span></code></pre></div>
<p>Methodology and Assumptions</p>
<div class="section level2">
<h2 id="hypotheses">Hypotheses<a class="anchor" aria-label="anchor" href="#hypotheses"></a>
</h2>
<p>The null and alternative hypotheses for the equivalence test are as
follows:</p>
<div class="section level3">
<h3 id="difference-of-means-dom">Difference of Means (DOM)<a class="anchor" aria-label="anchor" href="#difference-of-means-dom"></a>
</h3>
<p>A common approach to assessing bioequivalence involves comparing the
log-transformed pharmacokinetic (PK) measures between the test and
reference products. This is done using the following interval (null)
hypothesis:</p>
<p>Null Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>):
At least one endpoint does not meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>0</mn></msub><mo>:</mo><msubsup><mi>m</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>−</mo><msubsup><mi>m</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>≤</mo><msub><mi>δ</mi><mi>L</mi></msub><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mtext mathvariant="normal">or</mtext><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><msubsup><mi>m</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>−</mo><msubsup><mi>m</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>≥</mo><msub><mi>δ</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for at least one</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_0: m_T^{(j)} - m_R^{(j)} \le \delta_L ~~ \text{or}~~ m_T^{(j)} - m_R^{(j)} \ge \delta_U \quad \text{for at least one}\;j</annotation></semantics></math></p>
<p>Alternative Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>1</mn></msub><annotation encoding="application/x-tex">H_1</annotation></semantics></math>):
All endpoints meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>1</mn></msub><mo>:</mo><msub><mi>δ</mi><mi>L</mi></msub><mo>&lt;</mo><msubsup><mi>m</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>−</mo><msubsup><mi>m</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><mo>&lt;</mo><msub><mi>δ</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for all</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_1: \delta_L&lt;m_{T}^{(j)}-m_{R}^{(j)} &lt;\delta_U \quad\text{for all}\;j</annotation></semantics></math></p>
<p>Here,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>m</mi><mi>T</mi></msub><annotation encoding="application/x-tex">m_T</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>m</mi><mi>R</mi></msub><annotation encoding="application/x-tex">m_R</annotation></semantics></math>
represent the logarithmically transformed mean responses of the test
product (the proposed biosimilar) and the reference product,
respectively. The equivalence limits,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>δ</mi><mi>L</mi></msub><annotation encoding="application/x-tex">\delta_L</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>δ</mi><mi>u</mi></msub><annotation encoding="application/x-tex">\delta_u</annotation></semantics></math>,
are typically chosen to be symmetric, such that
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>δ</mi><mo>=</mo><mo>−</mo><msub><mi>δ</mi><mi>L</mi></msub><mo>=</mo><msub><mi>δ</mi><mi>U</mi></msub></mrow><annotation encoding="application/x-tex">\delta = - \delta_L = \delta_U</annotation></semantics></math>.
The FDA further recommends that the equivalence acceptance criterion
(EAC) be defined as
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>δ</mi><mo>=</mo><mi>E</mi><mi>A</mi><mi>C</mi><mo>=</mo><mn>1.5</mn><msub><mi>σ</mi><mi>R</mi></msub></mrow><annotation encoding="application/x-tex">\delta = EAC = 1.5 \sigma_R</annotation></semantics></math>,
where
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>σ</mi><mi>R</mi></msub><annotation encoding="application/x-tex">\sigma_R</annotation></semantics></math>
represents the variability of the log-transformed endpoint for the
reference product.</p>
<p>The null hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>)
is rejected if, and only if, all null hypotheses associated with the
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>K</mi><annotation encoding="application/x-tex">K</annotation></semantics></math>
primary endpoints are rejected at a significance level of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>α</mi><annotation encoding="application/x-tex">\alpha</annotation></semantics></math>.
This ensures that equivalence is established across all endpoints
simultaneously.</p>
</div>
<div class="section level3">
<h3 id="ratio-of-means-rom">Ratio of Means (ROM)<a class="anchor" aria-label="anchor" href="#ratio-of-means-rom"></a>
</h3>
<p>The equivalence hypotheses can also be expressed as a Ratio of Means
(ROM):</p>
<p>Null Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>0</mn></msub><annotation encoding="application/x-tex">H_0</annotation></semantics></math>):
At least one endpoint does not meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>0</mn></msub><mo>:</mo><mfrac><msubsup><mi>μ</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><msubsup><mi>μ</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup></mfrac><mo>≤</mo><msub><mi>E</mi><mi>L</mi></msub><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mtext mathvariant="normal">or</mtext><mspace width="0.222em"></mspace><mspace width="0.222em"></mspace><mfrac><msubsup><mi>μ</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><msubsup><mi>μ</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup></mfrac><mo>≥</mo><msub><mi>E</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for at least one</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_0: \frac{\mu_T^{(j)}}{\mu_R^{(j)}} \le E_L ~~ \text{or}~~ \frac{\mu_T^{(j)}}{\mu_R^{(j)}} \ge E_U \quad \text{for at least one}\;j</annotation></semantics></math></p>
<p>Alternative Hypothesis
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>H</mi><mn>1</mn></msub><annotation encoding="application/x-tex">H_1</annotation></semantics></math>):
All endpoints meet the equivalence criteria:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>H</mi><mn>1</mn></msub><mo>:</mo><msub><mi>E</mi><mi>L</mi></msub><mo>&lt;</mo><mfrac><msubsup><mi>μ</mi><mi>T</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup><msubsup><mi>μ</mi><mi>R</mi><mrow><mo stretchy="true" form="prefix">(</mo><mi>j</mi><mo stretchy="true" form="postfix">)</mo></mrow></msubsup></mfrac><mo>&lt;</mo><msub><mi>E</mi><mi>U</mi></msub><mspace width="1.0em"></mspace><mtext mathvariant="normal">for all</mtext><mspace width="0.278em"></mspace><mi>j</mi></mrow><annotation encoding="application/x-tex">H_1: E_L&lt; \frac{\mu_{T}^{(j)}}{\mu_{R}^{(j)}} &lt; E_U \quad\text{for all}\;j</annotation></semantics></math></p>
<p>Here,
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>μ</mi><mi>T</mi></msub><annotation encoding="application/x-tex">\mu_T</annotation></semantics></math>
and
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>μ</mi><mi>R</mi></msub><annotation encoding="application/x-tex">\mu_R</annotation></semantics></math>
represent the arithmetic mean responses of the test product (the
proposed biosimilar) and the reference product, respectively.</p>
</div>
<div class="section level3">
<h3 id="regulatory-requirements">Regulatory Requirements<a class="anchor" aria-label="anchor" href="#regulatory-requirements"></a>
</h3>
<p>When evaluating bioequivalence, certain statistical and
methodological requirements must be adhered to, as outlined in the
European Medicines Agency’s bioequivalence guidelines <span class="citation">[@CHMP2010]</span>. These requirements ensure that the
test and reference products meet predefined criteria for equivalence in
terms of pharmacokinetic parameters. The key considerations are
summarized below:</p>
<ul>
<li>Hypothesis testing should be based on the ratio of the population
geometric means</li>
<li>The 90% confidence interval for the ratio of the test and reference
products should be contained within the acceptance interval of 80.00 to
125.00%.</li>
<li>A margin of clinical equivalence
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>Δ</mi><annotation encoding="application/x-tex">\Delta</annotation></semantics></math>)
is chosen by defining the largest difference that is clinically
acceptable, so that a difference bigger than this would matter in
practice.</li>
<li>The data should be transformed prior to analysis using a logarithmic
transformation and subsequently be analyzed using ANOVA</li>
</ul>
</div>
</div>
<div class="section level2">
<h2 id="log-transformation-and-parameter-adjustments-in-samplesize">Log-Transformation and Parameter Adjustments in sampleSize()<a class="anchor" aria-label="anchor" href="#log-transformation-and-parameter-adjustments-in-samplesize"></a>
</h2>
<p>In <a href="../reference/sampleSize.html">sampleSize()</a>, Ratio of
Means (ROM) tests are converted to Difference of Means (DOM) tests by
log-transforming the data. Equivalence limits are applied to the
log-transformed data, and the results are back-transformed to the
original scale for interpretation. This approach leverages the
log-normal distribution of pharmacokinetic (PK) measures like AUC and
Cmax.</p>
<div class="section level3">
<h3 id="logarithmic-mean">Logarithmic Mean<a class="anchor" aria-label="anchor" href="#logarithmic-mean"></a>
</h3>
<p>The logarithmic mean is derived from the provided
<code>mu_list</code> (arithmetic means) and <code>sigma_list</code>
(variances) using the following formula:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext mathvariant="normal">Logarithmic Mean</mtext><mo>=</mo><mo>log</mo><mrow><mo stretchy="true" form="prefix">(</mo><mtext mathvariant="normal">Arithmetic Mean</mtext><mo stretchy="true" form="postfix">)</mo></mrow><mo>−</mo><mfrac><mn>1</mn><mn>2</mn></mfrac><mtext mathvariant="normal">Variance</mtext></mrow><annotation encoding="application/x-tex">\text{Logarithmic Mean} = \log(\text{Arithmetic Mean}) - \frac{1}{2}\text{Variance}</annotation></semantics></math>
This formula adjusts the arithmetic mean to account for the skewness of
log-normal data, ensuring that the central tendency on the log scale
aligns with the transformed data.</p>
</div>
<div class="section level3">
<h3 id="logarithmic-variance-transformation">Logarithmic Variance Transformation<a class="anchor" aria-label="anchor" href="#logarithmic-variance-transformation"></a>
</h3>
<p>To fully operate within the log-normal framework, the variances on
the original scale (<code>sigma_list</code>) must also be transformed.
The variance on the log scale is calculated using the normalized
variance formula:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext mathvariant="normal">Logarithmic Variance</mtext><mo>=</mo><mo>log</mo><mrow><mo stretchy="true" form="prefix">(</mo><mn>1</mn><mo>+</mo><mfrac><msup><mi>σ</mi><mn>2</mn></msup><msup><mi>μ</mi><mn>2</mn></msup></mfrac><mo stretchy="true" form="postfix">)</mo></mrow></mrow><annotation encoding="application/x-tex">
\text{Logarithmic Variance} = \log\left(1 + \frac{\sigma^2}{\mu^2}\right)
</annotation></semantics></math></p>
</div>
</div>
<div class="section level2">
<h2 id="testing-of-multiple-endpoints">Testing of multiple endpoints<a class="anchor" aria-label="anchor" href="#testing-of-multiple-endpoints"></a>
</h2>
<p>It is often required to investigate equivalence for more than one
primary variable. <span class="citation">[@sozu_sample_2015]</span> For
example, EMA recommends showing equivalence both for AUC and Cmax</p>
<p>A decision must be made as to whether it is desirable to</p>
<ul>
<li>Demonstrate equivalence for all primary endpoints: most common
setting (also known as <strong>multiple co-primary
endpoints</strong>)</li>
<li>Demonstrate equivalence for at least one of the primary endpoints
(also known as <strong>multiple primary endpoints</strong>)</li>
</ul>
<div class="section level3">
<h3 id="multiplicity">Multiplicity<a class="anchor" aria-label="anchor" href="#multiplicity"></a>
</h3>
<p>When a trial aims to evaluate the joint effects across all
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>m</mi><annotation encoding="application/x-tex">m</annotation></semantics></math>
co-primary endpoints <span class="citation">[@sozu_sample_2015]</span>,
no multiplicity adjustment is required to control the Type I error rate,
as all null hypotheses must be rejected to establish equivalence.
However, as the number of endpoints
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mi>K</mi><annotation encoding="application/x-tex">K</annotation></semantics></math>)
increases, the Type II error rate also increases. <span class="citation">[@mielke_sample_2018]</span> This leads to the
following implications:</p>
<ul>
<li>The power to detect equivalence decreases for a fixed sample
size.</li>
<li>The probability of trial success is reduced as more endpoints are
evaluated simultaneously.</li>
</ul>
</div>
</div>
<div class="section level2">
<h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">

      </div>

</div>



      <footer><div class="copyright">
  <p></p>
<p>Developed by Thomas Debray, Johanna Muñoz, Dewi Amaliah, Biogen Inc.</p>
</div>

<div class="pkgdown">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

      </footer>
</div>






  </body>
</html>
